About Tenegliptin with Metformin Combination
Tenegliptin with Metformin Combination is a reliable and effective medication specifically formulated to manage Type 2 Diabetes Mellitus in adults and aged individuals. Available in tablet form, this medication combines the benefits of Tenegliptin and Metformin in three variants: Auctista-20 (Tenegliptin 20 mg), Auctista-M 500 (Tenegliptin 20 mg + Metformin 500 mg SR), and Auctista-M 1000 (Tenegliptin 20 mg + Metformin 1000 mg SR). Tenegliptin enhances glycemic control by inhibiting DPP-4 enzyme activity, while Metformin provides sustained-release action for better glucose management and improved insulin sensitivity. Designed for specific use, this combination is ideal for regulating blood sugar levels effectively. This product is suitable for diabetes management in patients requiring tailored control solutions.
FAQs of Tenegliptin with Metformin Combination:
Q: What is the primary purpose of Tenegliptin with Metformin Combination?
A: The primary purpose of this medication is to manage Type 2 Diabetes Mellitus effectively by controlling blood sugar levels.
Q: Who can use Tenegliptin with Metformin Combination?
A: This medication is suitable for adults and aged individuals diagnosed with Type 2 Diabetes Mellitus.
Q: What variants are available in this medication?
A: It is available in three variants: Auctista-20, Auctista-M 500, and Auctista-M 1000, containing different compositions of Tenegliptin and Metformin.
Q: What is the role of Tenegliptin in this combination?
A: Tenegliptin helps enhance glycemic control by inhibiting the DPP-4 enzyme, which assists in better glucose regulation.
Q: What is the advantage of the sustained-release (SR) form of Metformin?
A: The sustained-release form of Metformin ensures prolonged glucose management with improved insulin sensitivity for better diabetes control.